
Sign up to save your podcasts
Or


Madison Carter is a fearless investigative reporter. She takes no day for granted because she lives with type 1 diabetes (T1D). Dr. Doug Melton is a world-renowned stem cell researcher and distinguished fellow at Vertex – and his now grown children, Sam and Emma, live with T1D. Along with scientists like Dr. Felicia Pagliuca, who leads Vertex’s research into T1D, he’s been on a quest to help Madison, Sam, Emma, and others like them by investigating the disease at a cellular level.
Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.
Featured guests:
Madison Carter is an investigative journalist with 11Alive News, an NBC affiliate in Atlanta, GA. She's living with type 1 diabetes.
Aaron Kowalski is the President and CEO of JDRF.
Felicia Pagliuca is the Disease Area Executive, Type 1 Diabetes, at Vertex Pharmaceuticals
Doug Melton leads investigations into treatments for Type 1 Diabetes at Vertex Pharmaceuticals. He is renowned for his stem cell research at Harvard University. Read more about Vertex's approach to targeting type 1 diabetes
Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.
By Vertex Pharmaceuticals4.9
3535 ratings
Madison Carter is a fearless investigative reporter. She takes no day for granted because she lives with type 1 diabetes (T1D). Dr. Doug Melton is a world-renowned stem cell researcher and distinguished fellow at Vertex – and his now grown children, Sam and Emma, live with T1D. Along with scientists like Dr. Felicia Pagliuca, who leads Vertex’s research into T1D, he’s been on a quest to help Madison, Sam, Emma, and others like them by investigating the disease at a cellular level.
Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.
Featured guests:
Madison Carter is an investigative journalist with 11Alive News, an NBC affiliate in Atlanta, GA. She's living with type 1 diabetes.
Aaron Kowalski is the President and CEO of JDRF.
Felicia Pagliuca is the Disease Area Executive, Type 1 Diabetes, at Vertex Pharmaceuticals
Doug Melton leads investigations into treatments for Type 1 Diabetes at Vertex Pharmaceuticals. He is renowned for his stem cell research at Harvard University. Read more about Vertex's approach to targeting type 1 diabetes
Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.

32,044 Listeners

30,719 Listeners

435 Listeners

1,383 Listeners

112,920 Listeners

9,530 Listeners

323 Listeners

8,809 Listeners

5,566 Listeners

9,888 Listeners

34 Listeners

2,079 Listeners

16,062 Listeners

19 Listeners

317 Listeners